Business Context and Reporting Period
This Form 8-K Current Report was filed by Charles River Laboratories International, Inc. on February 18, 2026. The filing discloses the appointment of a new Chief Financial Officer and details the associated compensatory arrangements.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on executive compensation terms.
Material Changes and Executive Appointment
The Company announced the appointment of Glenn Coleman as Corporate Executive Vice President and Chief Financial Officer, effective with a tentative start date of April 6, 2026. Mr. Coleman succeeds Michael G. Knell, who served as interim CFO since September 2025 and will remain as Corporate Senior Vice President and Chief Accounting Officer.
Mr. Coleman brings over 30 years of experience, most recently serving as CFO and Chief Administrative Officer of Premier, Inc., and previously holding CFO roles at DENTSPLY SIRONA Inc. and Integra Life Sciences Holdings Corporation.
Compensation Terms and Outlook
The employment offer letter outlines the following material compensation terms for Mr. Coleman:
- Base Salary: $800,000 annually, with eligibility for future increases based on performance.
- Annual Bonus: Targeted at 85% of gross annual base salary for 2026, pro-rated to the hire date.
- Annual Equity Award (2026): Grant value of $3,000,000, comprised of 60% Performance Share Units (PSUs) and 40% Restricted Stock Units (RSUs).
- One-Time New Hire Cash Award: $1,875,000 gross, paid in two installments ($1,000,000 after six months; $875,000 after 12 months).
- One-Time New Hire Equity Award: Grant value of $3,500,000 in RSUs, vesting 25% annually over four years.
The filing states there are no family relationships between Mr. Coleman and any director or executive officer requiring disclosure under Item 404(a) of Regulation S-K.
Investor Verification Checklist
- Verify the exact start date of April 6, 2026, and any potential delays.
- Review the full text of the Employment Offer Letter (Exhibit 10.1) for specific vesting conditions and performance metrics for the PSUs.
- Confirm the pro-rata calculation for the 2026 bonus based on the actual hire date.
- Monitor the transition of duties from interim CFO Michael G. Knell to Glenn Coleman.